Lets hope to achieve our long run planned objectives – for the welfare of CML patients in Uzbekistan!

Due to
Collaboration MoU between Federal Center named Almazova, St.Petersburg, Russia
under Prof.Zarizkiy and Research Institute of Hematology and Blood transfusion
MoH of Uzbekistan under main hematologist of the country Dr.Kazakbaeva and by
support of Max in contextual communication support , there are  planned research works on CML treatment and
monitoring/adjacent symptoms with Glivec in CML.
Using these
scientific Project, we plan to have following outcomes:
1.       Awareness about these issues among
international auditorium and scientists;
2.       Participation in the international
Multicentral investigations;
3.       Awareness of local community and
state stakeholders about CML issues;
4.        Diagnostics and monitoring of the treatment options
for patients with CML.
There are already 15 patients of GIPAP Uzbekistan were underwent bcr/abl
tests for monitoring of the treatment with Glivec for free under this project
plan at the Centre in St.Petersburg.

Lets hope to achieve our long run planned objectives – for the welfare
of CML patients in Uzbekistan!

Leave a Reply

Your email address will not be published. Required fields are marked *